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ABSTRACT
The potent antiretroviral protein APOBEC3G (A3G)
specifically targets and deaminates deoxycytidine
nucleotides, generating deoxyuridine, in single
stranded DNA (ssDNA) intermediates produced dur-
ing HIV replication. A non-catalytic domain in A3G
binds strongly to RNA, an interaction crucial for re-
cruitment of A3G to the virion; yet, A3G displays
no deamination activity for cytidines in viral RNA.
Here, we report NMR and molecular dynamics (MD)
simulation analysis for interactions between A3Gctd
and multiple substrate or non-substrate DNA and
RNA, in combination with deamination assays. NMR
ssDNA-binding experiments revealed that the inter-
action with residues in helix1 and loop1 (T201-L220)
distinguishes the binding mode of substrate ssDNA
from non-substrate. Using 2′-deoxy-2′-fluorine sub-
stituted cytidines, we show that a 2′-endo sugar con-
formation of the target deoxycytidine is favored for
substrate binding and deamination. Trajectories of
the MD simulation indicate that a ribose 2′-hydroxyl
group destabilizes the - stacking of the target cy-
tosine and H257, resulting in dislocation of the tar-
get cytosine base from the catalytic position. Inter-
estingly, APOBEC3A, which can deaminate ribocy-
tidines, retains the ribocytidine in the catalytic po-
sition throughout the MD simulation. Our results in-
dicate that A3Gctd catalytic selectivity against RNA
is dictated by both the sugar conformation and 2′-
hydroxyl group.
INTRODUCTION
Cytidine deaminases perform a variety of functions ranging
from diversification of antibodies to defense against viral
infection. Four members of the APOBEC3 (A3) family of
cytidine deaminases (A3D, A3F, A3G and A3H) have vary-
ing degrees of effectiveness in restricting HIV-1 infection
(1–6). Restrictive A3 proteins are encapsidated during viral
replication by associating with viral and cellular RNAs, and
transported in the budding virion to the target cell. During
the course of viral reverse transcription, a transient single-
strandedDNA (ssDNA) intermediate is formed. Restrictive
A3 proteins bind to the ssDNA intermediate and deaminate
cytosine bases to uracil in preferred polynucleotide con-
texts (5′-TC for A3D, A3F and A3H, and 5′-CC for A3G)
(7). Upon copying of the ssDNA intermediate to form the
dsDNA required for successful integration of the HIV-1
genome into the host DNA, mutated uracils base pair with
adenines resulting inG toA hypermutation and loss of cod-
ing integrity (8). Interestingly, even though these restrictive
A3 proteins bind tightly to RNA in the cell (9,10), they do
not catalyze cytosine deamination in the context of RNA
(11,12). The mechanism by which these A3 proteins dis-
tinguish between relatively rare single stranded DNAs and
the abundant single stranded RNA present in the cellular
milieu has been a perplexing question. Without the abil-
ity to selectively exclude ribocytidines from deamination,
mRNAwould acquire lethal amounts of nonsense and mis-
sense mutations[e.g., (13)], and without the ability to inter-
act with RNA, A3 proteins would not be able to exert re-
strictive pressure during HIV infection since encapsidation
is essential for deamination of the HIV-1 genome [e.g. (6)].
Sharma and co-workers observed the deamination of RNA
byA3G in natural killer cells, lymphoma cell lines andCD8-
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positive T cells under specific conditions, such as cellular
crowding and hypoxia, but not in cells under normal con-
ditions (14). Since A3G strongly disfavors ribocytidine as a
substrate in vitro (11,12), the physiological function ofRNA
deamination by A3G remains elusive.
Structures of the catalytically active subunits of A3A,
A3B, A3C, A3F, A3G and A3H have been determined in
the absence of ssDNA by us (15–19) and others (20–29).
We (30) and another group (31) also determined struc-
tures of A3A bound to ssDNA, which provided insights
of static interactions between substrate ssDNA and protein
at the catalytic site. In the A3A–ssDNA co-crystal struc-
tures, the ssDNA exists in a tightly curved conformation
with three nucleotides (the target deoxycytidine and flank-
ing nucleotides) forming hydrogen bonds and – stack-
ing interactions with A3A, and the sugar of the target de-
oxycytidine adopting the C2′-endo conformation typically
found in DNA (30,31). Most recently, we determined the
structure of the ssDNA-bound A3G catalytic domain us-
ing a variant of A3Gctd (A3G-CTD2) that has strong affin-
ity for ssDNA containing a hotspot sequence, 5′-TCCCA
(32). In comparison to the A3A–ssDNA co-crystal struc-
ture, the ssDNA has a more extended conformation and
larger contact surface with A3G-CTD2, by interacting with
five nucleotides instead of only three. Although this co-
crystal structure provided atomic details of static interac-
tions between the hotspot nucleotides and the protein, the
mechanism by which A3G strongly disfavored ribocytidine
as a substrate was not revealed. In particular, a 2′-OH could
fit within the spatial position of the 2′-H without significant
steric hindrance (32). Previously, Nabel et al. reported that
the C2′-endo sugar conformation was important for the ef-
ficiency of deoxycytidine deamination catalyzed by human
activation induced deaminase (AID) andmouseAPOBEC1
(33). This finding may or may not be applicable for A3G
because AID and mouse APOBEC1 are substantially dif-
ferent from A3G in regard to physiological targets; AID
deaminates deoxycytidines in particular 5′-A/T-2A/G-1C0
hotspots of the immunoglobulin genes undergoing tran-
scription (34), whereas APOBEC1 deaminates a specific cy-
tidine in the apolipoprotein B (Apob) pre-mRNA (35,36).
Importantly, APOBEC1 but not A3G, requires an addi-
tional factor for deamination site selection and activity in
cells; anRNA-binding protein, namely theAPOBEC1 com-
plementation factor or A1CF (37,38). For AID, different
studies have found that various proteins interact with AID
(39,40). In this study, we interrogate the differences in the in-
teraction modes of A3Gctd for substrate or non-substrate
ssDNAs, and the exclusion mechanisms for ribocytidine
from deamination. We show that the mode of interaction
including extent, intensity and time-scale, determined by
NMR titration experiments, clearly distinguish the catalyt-
ically productive binding mode for substrate ssDNA from
the inactive mode for non-substrate. In addition, we reveal
the importance of 2′-endo sugar conformation for catalyt-
ically productive binding using 2′-deoxy-2′-fluorine substi-
tuted cytidines as substrates. Furthermore, molecular dy-
namics (MD) simulations indicate that 2′-OH causes the
target ribocytidine to dislocate from the catalytic position
for A3Gctd but not for A3A, consistent with A3A’s ability
to deaminate ribocytidine.
MATERIALS AND METHODS
Plasmid generation and protein purification
The pGEX-6P-1 vector (GE Healthcare Life Science) con-
taining the C-terminal catalytic domain of A3G (A3Gctd),
residues 191–384, with the previously reported 2K3A mu-
tations (L234K, C243A, F310K, C321A, C356A) (15)
was used as the template for Quikchange mutagenesis
(Stratagene/Agilent Technologies) to introduce E259A sub-
stitution. Escherichia coli were transformed with the plas-
mid, grown to OD 0.5 at 37◦C followed by a reduction in
temperature to 17◦C for 30 min, and protein expression was
induced using a 0.1 mM final concentration of isopropyl
-D-1-thiogalactopyranoside (IPTG). The cells were lysed
using sonication into buffer containing 50 mM sodium
phosphate pH 7.3, 100 mM NaCl, 2 mM DTT, 0.002%
Tween 20. Following high-speed centrifugation, the super-
natant was bound to glutathione sepharose resin (Gen-
Script) and washed under high salt and high detergent con-
ditions, 400 mM NaCl and 0.06% Tween 20, followed by
twowashes in low salt and low detergent conditions, 30mM
NaCl and 0.002% Tween 20. The GST-tag was removed us-
ing PreScission protease (GE Healthcare Life Science) in
50 mM sodium phosphate buffer at pH 7.3 with 100 mM
NaCl, 2 mM DTT and 0.002% Tween 20. Following cleav-
age, the protein was dialyzed into sample buffer containing
50 mM sodium phosphate pH 6.0, 100 mM NaCl, 2 mM
DTT, 0.002% Tween 20 and 50 M ZnCl2.
NMR spectroscopy
All multi-dimensional NMR spectra were acquired on an
850 MHz Bruker Ascend spectrometer equipped with a
5 mm Z-gradient TCI cryoprobe. Samples contained a fi-
nal volume of 300L (97% H2O/3% D2O, v/v), and spec-
tra were taken at 293 K. Backbone resonance assignments
for the A3Gctd-2K3A-E259A mutant were derived using
TROSY versions of a standard set of triple resonance
spectra (HNCA, HN(CO)CA, HNCACB, HN(CO)CACB,
HNCO, HN(CA)CO) on uniformly 15N/13C labeled pro-
tein with 85% random deuteration at pH 7.3. Assignments
were transferred to pH 6.0 HSQC spectrum by titrating pH
to identify relevant peak shifts. 15N-HSQC with ssDNA
titrations were collected on 0.2 mM 15N-labeled A3Gctd-
2K3A-E259A samples at pH 6.0 with unlabeled ssDNA at
ratios of 1:1, 1:2 and 1:5 (A3Gctd-2K3A-E259A:ssDNA).
Each titration point was collected with 128 transients and
100 real data points in the indirect 15N dimension. Chemical
shift and intensity changes were monitored through a series
of spectra at varying relative concentration ratios. Chemical
shift changes were calculated using the equation:
δppm =
√
(δHx − δH0)2 +
(
δNx − δN0
5
)2
Intensity changes were calculated using the difference
in peak height at the center of the 15N-HSQC peak be-
tween the unbound and bound spectra divided by the un-
bound peak height. Real-time 1D 1H NMR deaminase
assays were performed on Bruker Avance III 600 MHz
NMR spectrometer at 20◦C in buffer containing 50mM
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sodium phosphate pH 6.0, 100 mM NaCl, 1 mM DTT,
10 M ZnCl2 and 0.002% Tween-20. Oligonucleotide sub-
strate concentrations of 150 M were used in the assays
with enzyme concentrations ranging from 1.5 to 50 M.
Spectra were analyzed using Topspin 3.5 software package
(Bruker Corporation, Billerica, MA, USA).
DNA oligomers
Oligonucleotides containing standard DNA and RNA
bases were synthesized by Integrated DNA Technolo-
gies (IDT). Oligonucleotides containing 2′-deoxy-2′-
fluororibonucleic acid (2′-F-RNA) and 2′-deoxy-2′-
fluoroarabonucleic acid (2′-F-ANA) at the underlined
cytosine position in the 5′-ATTCCCAATT oligonucleotide
were synthesized by Boston Open Labs.
Microscale Thermophoresis assay (MST)
The binding affinity of purified A3Gctd-2K3A-E259A
with 9nt ssDNAs (IDT), including 5′-AATCCCAAA,
5′-AATCCdeoxyUAAA, 5′-AATCdeoxyUdeoxyUAAA,
5′-AATCCriboseCAAA, 5′-ATTCC(2′-F-ANA)CAATT
and 5′-ATTCC(2′-F-RNA)CAATT, were measured using
Monolith NT.115 (Nano Temper Technologies) (41).
RED-tris-NTA fluorescent dye solution was prepared at
100 nM in the MST buffer (50 mM phosphate pH 6.0,
100 mM NaCl, 1 mM DTT, 0.002% Tween-20, 20 M
ZnCl2). A3Gctd-2K3A-E259A was mixed with dye at final
concentration of 100 nM and incubated for 30 min at room
temperature followed by centrifugation at 15 000 g for 10
min. The ssDNAs were prepared to stock concentration
of 64 mM for AATCCCAAA, 5′-AATCCdeoxyUAAA,
5′-AATCdeoxyUdeoxyUAAA, 5′-AATCCriboseCAAA,
or 32 mM for 5′-ATTCC(2′-F-ANA)CAATT and 5′-
ATTCC(2′-F-RNA)CAATT) in the MST buffer. To
determine the binding affinity, 10 l of ssDNA solution
at 16 different concentrations, ranging from 32 mM to
0.24 M, or 16 mM to 0.12 M for 5′-ATTCC(2′-F-
ANA)CAATT and 5′-ATTCC(2′-F-RNA)CAATT, were
prepared in LoBind centrifuge tubes (Fisher Scientific),
then 10 l of fluorescent labelled A3Gctd-2K3A-E259A
solution (100 nM) was added to each tube. The mixtures
were incubated at 4◦C to reach equilibrium. Each incubated
solution was loaded into a Nano Temper MST premium
coated capillary. The measurement was performed at room
temperature using 40% LED power and 20% MST power.
The experiment was repeated three times using freshly
purified protein at each time, and data analysis was carried
out using Nano Temper analysis software (MO affinity).
Molecular dynamics simulations
The structures of wild type A3Gctd with 5′-TCCCAA or
5′-TCCrCAA were modeled starting from ssDNA-bound
A3Gctd crystal structure (PDB ID: 6BUX) through pro-
gram Modeller 9.15 using basic modeling. The structures
of wild type A3A with 5′-AATCGAA or 5′-AATrCGAA
weremodelled based onA3ADNA-bound crystal structure
(PDB ID: 5KEG) using the same method. The phosphate
groups of 5′ T base in all structures were removed to prevent
strong electronegative environment. All molecular dynam-
ics simulations were performed using Desmond (42) from
Schro¨dinger. The models were first optimized using Protein
PreparationWizard at pH 6.5. The simulation systems were
then built through Desmond System Setup using OPLS3
force field (43). Simple point charge (SPC) water model was
used for solvation with cubic boundary conditions and 12
A˚ buffer box size. The final system was neutral and had
0.15M sodium chloride. The simulation systemwas first en-
ergy minimized with gradually reduced restraints (1000, 5,
0 force constant) on backbone and solute heavy atoms. A
multi-stage MD simulation protocol was used. Briefly, the
system was simulated using NPT ensemble with gradually
increased simulation time (24, 50 and 500 ps) and decreased
restraints on the solute heavy atoms to no restraints. The fi-
nal production stage was performed at 300K and 1 bar with
no restraints using NPT ensemble. 100 ns MD simulations
were performed for all DNA-bound structures. The analy-
sis of MD simulations was performed separately for each
trajectory. The RMSD and RMSF of protein and DNA
molecule were calculated using Simulation Interactions Di-
agram from Schro¨dinger. Hydrogen bond occupancies over
the trajectories and the side chain dihedral angles were cal-
culated using programVMD.A hydrogen bond was defined
as having a donor-acceptor distance of <3.6 A˚ and involv-
ing polar atoms nitrogen, oxygen, sulfur and fluorine. The
donor-hydrogen-acceptor angle was defined as being less
than 30 degrees. The trajectories from MD simulations for
RMSD, distance and dihedral analysis were aligned based
on whole molecules.
RESULTS
Assigning NMR signals of A3Gctd-2K3A-E259A at pH 6.0
Wild-type A3Gctd has weak affinity for ssDNA at neutral
pH, making detection difficult of significant NMR chem-
ical shift perturbations upon ssDNA binding (15,21). En-
zymatic kinetics analysis of A3Gctd at pH 6 suggested that
A3Gctd bound ssDNAwith a higher affinity (44), but wild-
type A3Gctd was not stable enough to conduct lengthy
NMR experiments at that pH with high protein concentra-
tion. Therefore, we used a variant A3Gctd, termedA3Gctd-
2K3A that contained five amino acid substitutions (L234K,
C243A, F310K, C321A andC356A) which enhance the sol-
ubility and stability of protein, without altering catalytic ac-
tivity, structure, or HIV-1 restriction (15,17,45). To observe
interaction and compare differences between substrate and
non-substrate ssDNAs without ongoing catalytic reaction,
we produced a catalytically inactive variant of A3Gctd-
2K3A by introducing a single alanine point mutation at
the catalytic glutamate (E259A), termed A3Gctd-2K3A-
E259A. We completed the assignment of backbone NMR
signals of A3Gctd-2K3A-E259A by using standard triple
resonance NMR experiments at pH 7.3, then transferred
the assignments to the spectrum recorded at pH 6.0 by fol-
lowing peak shifts throughout pH titration from pH 7.3 to
pH 6.0. We were able to assign most of the resolved NMR
signals in the 15N-HSQC spectrum at pH 6.0 (Figure 1).
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Figure 1. NMR signal assignments of A3Gctd-2K3A-E259A at pH 6.0. 1H–15NHSQC spectrum of A3Gctd-2K3A-E259A. Inset locations indicated with
colored boxes correspond to expanded inset spectrum borders.
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Identification of ssDNA-binding surfaces of A3Gctd
A3Gctd deaminates the 3′ C in the 5′-CCC motif 45
times more efficiently than the middle C, and does not
deaminate the 5′ C in vitro (44,46–48). In order to de-
termine interactions that are responsible for this dispar-
ity, we mixed ssDNA to a sample containing catalyt-
ically inactive A3Gctd-2K3A-E259A and observed in-
teraction between the protein and ssDNA. We mixed
the substrate ssDNA (5′-AATCCCAAA), the interme-
diate product (5′-AATCCdeoxyUAAA), the final prod-
uct (5′-AATCdeoxyUdeoxyUAAA), or a ribocytidine sub-
stituted ssDNA (5′-AATCCrCAAA) to A3Gctd-2K3A-
E259A, and compared chemical shift perturbations (CSP)
and signal intensity changes of their 15N-HSQC spectra.
The 15N-HSQC spectrum of A3Gctd-2K3A-E259A
showed substantial perturbations upon adding 5′-
AATCCCAAA (Figure 2A). This data was quantified
as described in Methods and plotted as CSP (red with right
axis) and signal intensity changes (gray with left axis) in
Figure 2C. Both analyses revealed three primary regions
perturbed upon 5′-AATCCCAAA binding. These three
regions, binding regions 1, 2 and 3 or BR1, BR2 and BR3,
form a continuous surface in the 3D structure of ssDNA-
free A3Gctd (PDB ID: 4ROV) (25) (Figure 2D). BR1
spans residues T201-L220, which includes residues located
in helix1 (T201-N207) and loop1 (N208-T218). Especially,
W211 and R215, both located in loop1, lost >70% of their
signal intensity suggesting direct interactions with DNA.
BR2 spans residues R238-K270, and includes -sheet2′,
loop3 and helix2. Residues sequentially close to N244 and
H257, both located in loop3, showed substantial CSP and
intensity changes (Figure 2C). These changes are likely
caused by the direct interaction of N244 and H257 with the
target deoxycytidine, as observed in the co-crystal structure
of A3Gctd-ssDNA (32). It is noteworthy that R238, located
in the short loop between -sheet2 and -sheet2′, showed
substantial perturbation, although it is not located at the
catalytic site. Furthermore, F262, L263, V265 and W269,
all located in helix2 with their side chains directed toward
the inside of the protein and forming a hydrophobic core,
displayed DNA-bound as well as DNA-unbound NMR
signals following substrate addition (Figure 2B), indicating
slow exchange dynamics between bound and unbound
states. BR3 includedW285 and T311-E330, which contains
loop7 (T311-G319), previously suggested to be impor-
tant for recognition of the hotspot sequence (20,49,50).
Especially, W285 located at the catalytic pocket (15,20)
as well as loop7 residues, A312, R313, Y315 and D316,
displayed substantial CSP with slow exchange dynamics
(Figure 2B). These perturbations were consistent with the
co-crystal structure (32) as R313, Y315 and D316 had
direct interactions with ssDNA. The exchange of bound
and unbound states of loop7 residues likely destabilized
helix4 (E323–E330), since residues located in helix4 showed
>60% reductions in signal intensity.
We next compared CSP and intensity changes
for 5′-AATCCCAAA with the intermediate prod-
uct, 5′-AATCCdeoxyUAAA, by subtracting the
changes for 5′-AATCCCAAA from the changes for 5′-
AATCCdeoxyUAAA (‘delta – delta’ plot, Figure 3A). Raw
data including NMR spectra, quantified CSP and intensity
changes upon the addition of 5′-AATCCdeoxyUAAA
are provided in Supplementary Figures S1A and S2A,
respectively. We found that 5′-AATCCdeoxyUAAA
engaged all three binding regions described above for
5′-AATCCCAAA, however, the key difference was that
BR1 residues displayed reduced chemical shift changes
and signal intensity changes (appearing as negative red
and gray bars in Figure 3A), indicating lesser interaction
of BR1 with 5′-AATCCdeoxyUAAA. In addition, Figure
3A revealed that the exchange rate between bound and un-
bound states became faster with 5′-AATCCdeoxyUAAA
than 5′-AATCCCAAA, as residues in BR2 and BR3
indicated reduced chemical shift changes (negative red
bars) but increased intensity reduction (positive gray
bars) caused by line-broadening due to exchange between
bound and unbound states. The faster exchange rate
with 5′-AATCCdeoxyUAAA was also evident in the
spectrum (Supplementary Figure S1A) since there was no
residue showing two distinct bound and unbound signals,
as had been displayed upon binding 5′-AATCCCAAA
(Figure 2B). 5′-AATCCdeoxyUAAA contained a 5′-CC
deamination motif, and the underlined C was presumably
positioned at the catalytic site. The lesser interaction with
5′-CC compared to 5′-CCC was consistent with deamina-
tion efficiency since A3Gctd deaminates 5′-CCC 45-times
more efficiently than 5′-CCdeoxyU (44).
Next, we compared a non-substrate ssDNA with the
substrate by using ‘delta – delta’ plots, subtracting the
changes for 5′-AATCCCAAA from the changes for
5′-AATCdeoxyUdeoxyUAAA (Figure 3B). NMR spec-
trum, quantified CSP and intensity changes upon mix-
ing with 5′-AATCdeoxyUdeoxyUAAA are provided in
Supplementary Figures S1b and S2b, respectively. 5′-
AATCdeoxyUdeoxyUAAA is the final product of the
deamination of 5′-CCC as A3Gctd does not deaminate
the 5′-TC motif in vitro (46,47,51). All three binding re-
gions, BR1, BR2 and BR3, demonstrated greatly reduced
chemical shift changes and signal intensity changes com-
pared with 5′-AATCCCAAA (appearing as negative red
and gray bars in Figure 3B), indicating interactions were
lost. Although interactions with BR1 and BR3 were almost
completely lost, W211NE (BR1), R215 (BR1) and D316
(BR3) retained significant reduction of signal intensities,
suggesting that these residues still engage the DNA (Sup-
plementary Figure S2b). We tested another non-substrate
ssDNA containing a ribocytidine at the target position,
5′-AATCCriboseCAAA, by using ‘delta–delta’ plots (Fig-
ure 3C). NMR spectrum and CSP, intensity changes are
provided in Supplementary Figures S1c and S2c, respec-
tively. Figure 3C displayed very similar profile to Fig-
ure 3B as all three binding regions substantially reduced
both chemical shift changes and signal intensity changes
compared with 5′-AATCCCAAA. Especially, BR1 residues
lost interaction with the exception of W211NE and R215.
BR3 was slightly more involved in the interaction with 5′-
AATCCriboseCAAA than 5′-AATCdeoxyUdeoxyUAAA
as BR3 residues showed smaller loss of signal intensity
changes (shorter negative gray bars in Figure 3C).
The affinities of A3Gctd-2K3A-E259A for above sub-
strate and non-substrate ssDNAs were assayed directly
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Figure 2. Chemical shift perturbation and signal intensity changes upon binding 5′-AATCCCAAA. (A) 1H–15N HSQC spectrum of 0.2 mM A3Gctd-
2K3A-E259A mixed with 1 mM 5′-AATCCCAAA (red) overlaid onto 0.2 mM A3Gctd-2K3A-E259A (black). Significantly shifted peaks are labeled. (B)
NMR signals of residues in slow exchange regime upon addition of 5′-AATCCCAAA. DNA-unbound signals are labeled unbound, whereas DNA-bound
signals are labeled bound. Intensities of unbound signals decrease, while intensities of bound signals increase, upon increment of the ssDNA concentration.
(C) Quantification of peak intensity changes (gray bars, left axis) and chemical shifts changes (red bars, right axis). Residues in BR1, BR2 and BR3 are
colored blue, magenta and yellow, respectively. Secondary structures within the binding regions are shown under the residues. (D) Three ssDNA binding
regions are shown on the surface of the structure of ssDNA-free wild typeA3Gctd (PDB ID# 4ROV). Binding region 1 (BR1, cyan) spans residues 201–220,
binding region 2 (BR2, magenta) spans residues 238–270, and binding region 3 (BR3, yellow) spans the non-consecutive residues 285, 311–330. Secondary
structures of binding regions are shown in cartoon models.
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Figure 3. Comparison of chemical shift perturbations and intensity changes upon binding substrate and non-substrate ssDNAs. ssDNA oligomers were
mixed withA3Gctd-2K3A-E259A at 1mM: 0.2mMconcentration ratio, and 1H–15NHSQC spectra were acquired (spectra are provided in Supplementary
Figure S1). Peak intensity changes and chemical shifts changes upon addition of ssDNA were quantified for each ssDNA (provided in Supplementary
Figure S2), then ‘delta––delta’ plots were made by subtracting the changes for 5′-AATCCCAAA from the changes for (A) 5′-AATCCdeoxyUAAA, (B)
5′-AATCdeoxyUdeoxyUAAA and (C) 5′-AATCCriboseCAAA. (D) shows the ‘delta – delta’ plot where the changes for 5′-AATCC(2′-F-ANA)CAAA
have been subtracted from the changes for 5′-AATCC(2′-F-RNA)CAAA. The differences of chemical shift changes and signal intensity changes are shown
by red bars (right axis) and gray bars (left axis), respectively.
by using microscale thermophoresis (MST) (41). The
apparent dissociation constant, Kd, was determined
for 5′-AATCCCAAA, 5′-AATCCdeoxyUAAA, 5′-
AATCdeoxyUdeoxyUAAA and 5′-AATCCriboseCAAA
to be 1.57 ± 0.16, 2.17 ± 0.25, 2.76 ± 0.28 and 6.65 ± 0.86
mM, respectively (Table 1; binding curves are provided in
Supplementary Figure S3). Although the differences of
Kd values among the ssDNAs were small, the direction
of changes of Kd values supported deamination activity
of A3Gctd as it showed stronger affinity for the substrate
(5′-AATCCCAAA) and weaker affinity for the product (5′-
AATCdeoxyUdeoxyUAAA), and the intermediate product
(5′-AATCCdeoxyUAAA) showed a Kd value between
the substrate and the product. 5′-AATCCriboseCAAA
displayed an affinity weaker than that of the product 5′-
AATCdeoxyUdeoxyUAAA, indicating that a ribocytidine
was disfavored more than deoxy-uridine for binding by
A3Gctd.
Collectively, NMR and MST experiments showed that
A3Gctd has multiple substrate and non-substrate ssDNA
binding modes with similar affinities, but one conformation
Table 1. Apparent Kd values of A3Gctd-2K3A-E259A for binding sub-
strate and non-substrate ssDNAs.
ssDNA sequence Kd [mM]
5′-AATCCCAAA 1.57 ± 0.16
5′-AATCCdUAAA 2.17 ± 0.25
5′-AATCdUdUAAA 2.76 ± 0.28
5′-AATCCrCAAA 6.65 ± 0.86
5′-AATCC(2′-F-RNA)CAAA 3.76 ± 0.30
5′-AATCC(2′-F-ANA)CAAA 1.74 ± 0.49
involved interaction with BR1, slightly enhancing binding,
and presumably positioned the target cytosine base into the
active site for the deamination to occur.
Effects of sugar conformation on ssDNA binding and deami-
nation
Two potential mechanisms could exclude ribocytidines
from catalysis by A3Gctd: the presence of the hydroxyl moi-
ety at the sugar C2′ position of the ribocytidine or the con-
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formation of the sugar; ribose prefers the C3′-endo confor-
mation whereas deoxyribose prefers the C2′-endo confor-
mation (Figure 4). To discriminate between these two pos-
sible mechanisms, we tested two fluorinated cytidine sub-
strates, the first containing a fluorine substituted for the C2′
hydroxyl of the ribose (2′-deoxy-2′-fluororibonucleic acid,
2′-F-RNA) and the second containing an arabinose sugar
with the C2′ hydroxyl substituted for fluorine (2′-deoxy-2′-
fluoroarabonucleic acid, 2′-F-ANA) (Figure 4). The 2′-F-
RNA cytidine presumably had the C3′-endo conformation
of the un-substituted ribose base, while the 2′-F-ANA cyti-
dine presumably preferred the C2′-endo conformation typ-
ically seen in DNA (52). Fluorine substitution retains an
electronegative atom at the C2′ position to mimic the pres-
ence of an oxygen atom with significantly weaker capability
to form a hydrogen bond.
We added 5′-ATTCC(2′-F-ANA)CAATT or 5′-
ATTCC(2′-F-RNA)CAATT to a sample of A3Gctd-
2K3A-E259A (NMR spectra and CSP/intensity changes
are provided in Supplementary Figures S1S and E and
S2D and E). Addition of 5′-ATTCC(2′-F-ANA)CAATT
resulted in moderate CSP and substantial intensity
changes in all BR1, BR2 and BR3 regions (Supplementary
Figure S2d). On the contrary, addition of 5′-ATTCC(2′-
F-RNA)CAATT showed limited CSP and moderate
reduction of NMR signal intensities across the pro-
tein, but did not display the intensive BR1 interaction
(Supplementary Figure S2e), suggesting that 5′-ATTCC(2′-
F-RNA)CAATT is not a substrate. Figure 3d shows the
‘delta-delta’ plot where the CSP and intensity changes for
5′-ATTCC(2′-F-ANA)CAATT are subtracted from the
changes for 5′-ATTCC(2′-F-RNA)CAATT. 5′-ATTCC(2′-
F-ANA)CAATT caused substantially increased reduction
of NMR signal intensities compared with 5′-ATTCC(2′-F-
RNA)CAATT (negative gray bars in Figure 3D) in BR1
and BR2, but less extent in BR3.
To compare differences in affinity, apparent dissocia-
tion constant, Kd, values were determined using MST.
Kd values were 1.73 ± 0.48 mM and 3.76 ± 0.30 mM
for 5′-ATTCC(2′-F-ANA)CAATT and 5′-ATTCC(2′-F-
RNA)CAATT, respectively (Table 1, binding curves are
provided in Supplementary Figure S3). The Kd value of
5′-ATTCC(2′-F-ANA)CAATT was similar to that of sub-
strate ssDNAs, including 5′-AATCCCAAA (Kd = 1.57
± 0.15 mM) and 5′-AATCCdeoxyUAAA (Kd = 2.17
± 0.25 mM), whereas the Kd value of 5′-ATTCC(2′-F-
RNA)CAATT was between the Kd values of two non-
substrate ssDNAs, 5′-AATCdeoxyUdeoxyUAAA and 5′-
AATCCriboseCAAA.
Since both NMR signal intensity changes and Kd values
suggested that 5′-ATTCC(2′-F-ANA)CAATT might be a
substrate for the deamination catalyzed byA3Gctd, we con-
ducted 1D 1H NMR deamination assays. Over the course
of 8 hours, we observed the appearance of the H5 sig-
nal from the deaminated C2′-F-arabinose uracil product
5′-ATTCC(C2′-F-ANA)UAATT at 5.58 ppm, followed by
the appearance of another H5 signal at 5.68 ppm from
the uracil from the product of deamination of the mid-
dle deoxycytidine, 5′-ATTCdeoxyU(C2′-F-ANA)UAATT
(Figure 5C). The deamination speed for the 2′-F-ANA cyti-
dine was 0.06 ± 0.01 reactions/min (Supplementary Figure
S4). We also tested whether 5′-ATTCC(2′-F-RNA)CAATT
could be deaminated by A3Gctd-2K3A, but over the course
of 8 h, no uracil signal was observed, confirming that the 2′-
F-RNA cytidine was not a substrate (Figure 5D).
Molecular dynamics simulations of A3Gctd–ssDNA and
A3A–ssDNA complexes
To reveal the atomic-level mechanism for how A3Gctd
strongly disfavors ribocytidine (rC) as a substrate, we in-
vestigated the stability of ssDNA in the active site through
molecular modeling and molecular dynamics (MD) simu-
lations. We modeled 5′-TCCCAA and 5′-TCCrCAA with
wild type A3Gctd based on the ssDNA-bound A3Gctd
crystal structure (PDB ID: 6BUX) and performedMD sim-
ulations. Both MD simulations converged during the 100
ns simulation time. The deoxycytidine (dC) remained in the
crystal structure conformation at the catalytic site during
the simulations with 5′-TCCCAA (Figures 6A–C, 7A, blue
and B). However, in the simulations with 5′-TCCrCAA, ss-
DNA still bound, but rC shifted ∼3 A˚ away relative to the
starting position within 10 ns of the MD simulation (Fig-
ures 6D–F, 7A, red and C). The relocation of rC was due
to conformational rearrangements induced by the hydroxyl
group attached to 2′C (2′-OH) in rC. H257, which is in close
proximity to rC, can form a hydrogen bond with 2′-OH (5
ns; Figure 6E), which in turn destabilized the stacking in-
teraction between the H257 imidazole ring and rC nucle-
obase. As a result, the critical hydrogen bonds stabilizing
co-crystal structure conformation of the target ribocytidine,
between the N244 sidechain and sugar, and between A258
backbone and nucleobase, were disrupted. The side chain of
N244 then flipped towards rC and formed a new hydrogen
bond with the rC base (10 ns; Figure 6F), and thus dislo-
cated the rC to a position that was incompatible with the
deamination reaction. rC was stable at this relocated po-
sition as it did not go back to the original catalytic posi-
tion during the rest of the MD simulation (Figure 7A, red;
movies of MD simulation trajectories are provided as Sup-
plementary information). Thus, our computational results
were in agreement with experimental data that A3G could
deaminate dC but not rC. Furthermore, we performed simi-
lar modeling andMD simulations for A3A as a comparison
since we observed binding (53) and deaminations of both
dC and rC by A3A (Supplementary Figure S5). The deami-
nation rate for rC was two orders of magnitude slower than
dC in an in vitro NMR-deamination assay (Supplementary
Figure S5). In agreement with experiments, the simulations
showed that both dC and rC were stable in the catalytic site
of A3A and maintained co-crystal structure conformation
throughout the MD simulation (Figure 7D–F).
DISCUSSION
BR1 interaction distinguishes catalytic binding from non-
catalytic binding
Characterizing the mechanism of substrate selection and
non-substrate exclusion by A3Gctd is important for the de-
velopment of inhibitors that can selectively modulate A3G
activity as well as other A3 enzymes, including those with
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Figure 4. Comparison of nucleotide sugar conformation. Varying functional group and stereochemistry at the C2′ position of the ribose ring impacts the
ribose ring conformation. (A) Stereochemistry at the C2′ position of the nucleotides used in this study. (B) Preferred conformations of the ribose ring
containing specified substitutions in polynucleotide contexts. Exo-conformations indicated by vertical lines connecting functional groups at the indicated
stereo-centers. Endo-conformations indicated by horizontal lines connecting functional groups.
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Figure 5. Real-time NMR deamination assays. (A) 1D 1H spectra series of 150 M 5′-ATTCCCAATT mixed with 1.5 MA3Gctd-2K3A. The H5 signal
of uracil from the deamination product 5′-ATTCCdUAATT appears at 5.64 ppm, another H5 signal of uracil from 5′-ATTCdUdUAATT product appears
at 5.73 ppm with concurrent shifting of the 3′ dU signal to 5.66 ppm. (B) 1D 1H spectral series of 150 M5′-ATTCCrCAATTmixed with 50 MA3Gctd-
2K3A. No deamination product was observed. (C) 1D 1H spectra series of 150 M 5′-ATTCC(2′-F-ANA)CAATT mixed with 30 MA3Gctd-2K3A. A
doublet signal of the (2′-F-ANA)U, which is the deamination product of (2′-F-ANA)C, was observed at 5.58 ppm. A doublet signal of the uracil resulted
from deamination of the middle C, 5′-CU(2′-F-ANA)U, later appears at 5.68 ppm with concurrent shifting of the 3′ (2′-F-ANA)U to 5.60 ppm. (D) 1D
1H spectral series of 150 M 5′-ATTCC(2′-F-RNA)CAATT mixed with 30 MA3Gctd-2K3A. No deamination product was observed.
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Figure 6. Snapshots from MD simulations with deoxycytidine and ribocytidine. All panels display the expanded view of the catalytic site of A3Gctd.
Zn2+ is shown as a gray sphere, and yellow dashed lines indicate possible hydrogen bonds. DNAs are shown in orange stick model, and nitrogen and
oxygen atoms are colored blue and red, respectively. (A), (B) and (C) are snapshots of the 5′-TCCCAA and A3Gctd complex at 0, 5 and 10 ns time points,
respectively, while (D), (E) and (F) are snapshots of the 5′-TCCrCAA and A3Gctd complex at 0, 5 and 10 ns time points, respectively.
possible links to carcinogenesis such as A3A and A3B
(54,55). Using a combination of experimental and com-
putational methods, we highlight protein-ligand interac-
tions critical for substrate binding that are absent for non-
substrates. Our NMR data show that ssDNA binding in-
terfaces of A3Gctd-2K3A form a continuous surface of the
protein engaging loops 1, 3 and 7 (Figure 2D). Intense in-
teractions with loop1 residues were observed only with sub-
strate ssDNAs (Figure 2C). This finding supports the im-
portance of loop1 residues for ssDNAbinding that has been
previously proposed based on the NMR and crystal struc-
tures of ssDNA-unboundA3Gctd (15,20), and further, Car-
penter et al. provided experimental evidence by swapping
loop1 regions between AID and A3Gctd (50). Our data is
also consistent with our recent co-crystal structure of A3G-
CTD2 and ssDNA in which W211, R213 and H216, all
in loop1, form direct interactions with DNA through –
stacking and hydrogen bonds (32). Ziegler and co-workers
recently reported an interesting co-crystal structure of Pot1-
fused-A3Gctd and ssDNA (56), and they suggested that
loop1 and loop7 residues, including P210, W211, I314 and
Y315, along with W285 interact with ssDNA nonspecifi-
cally during the search of deamination hotspots. Consistent
with their suggestion, we found thatW211, R215, D316 and
W285 were involved in the interactions with substrate as
well as non-substrate ssDNAs.
Allosteric regulation may be an effective strategy to de-
velop inhibitors of A3 activity as competitive inhibitors
have been elusive. The NMR signal perturbation data im-
ply possible allosteric sites to target for A3Gctd. In partic-
ular, the slow exchange regime of helix 2 residues suggests
that the reorientation of helix2 is an allosteric movement
coupled with the target cytosine base positioning in Zn2+
containing active site, since helix 2 contains H257 and E259
which coordinate the Zn2+. Another possible allosteric site
is 2′-strand (R238-L242) as the dynamic modulation of
this strand is most likely helping N244 to stabilize the target
deoxycytidine during catalysis (30–32,57–59).
A3Gctd suppresses the catalytic efficiency of ribocytidine
through sugar conformation and 2′-OH
Two distinct attributes of RNA could be responsible for
the lack of catalytic activity; the presence of the 2′-OH
directly, via steric clashing or unfavorable interaction, or
indirectly, via conformational impact on the structure
of the ribose ring that may prevent cytosine base ac-
cess to the catalytic site. ssDNAs containing a ribocyti-
dine at the target position have been shown to be ex-
cluded from deamination by A3G in vitro (11,12). Con-
sistently, binding of 5′-AATCCriboseCAAA to A3Gctd-
2K3A-E259A resulted in a pattern of perturbations sim-
ilar to that seen in 5′-AATCdeoxyUdeoxyUAAA, a non-
substrate ssDNA (Figure 3B and C). We observed a slightly
more extensive interaction for 5′-AATCCriboseCAAA
with BR3 (residues W285, T311-E330) than seen with 5′-
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Figure 7. Comparison of A3Gctd and A3A in MD simulations with ssDNAs containing dC or rC. (A) A3Gctd and (D) A3A root-mean-square-deviation
(RMSD) of the target deoxycytidine (dC) or ribocytidine (rC) duringMD simulation. RMSD of all heavy atoms of the target deoxycytidine or ribocytidine
are shown for 100 ns simulation time. dC or rC with A3Gctd is shown in blue and red respectively in (a), whereas dC or rC with A3A is shown in orange
and black respectively in (d). (B, C) and (E, F) Superposition of expanded views of the catalytic site of A3Gctd (B and C), and A3A (E and F). Zn2+
molecules are shown as spheres. The snapshots at 0 ns are colored blue, whereas the snapshot at 100 ns is colored yellow. DNAs are shown in stick model,
and nitrogen and oxygen atoms are colored blue and red, respectively. (B) 5′-TCCCAA and A3Gctd complex, (C) 5′-TCCrCAA and A3Gctd complex, (E)
5′-AATCGAA and A3A complex, and (F) 5′-AATrCGAA and A3A complex.
AATCdeoxyUdeoxyUAAA. This effect is likely due to
interactions between loop7 and the 5′-CC motif present
in 5′-AATCCriboseCAAA since loop7 recognizes the de-
oxycytidine flanking the 5′ side of the target deoxycyti-
dine in this motif. Nonetheless, 5′-AATCCriboseCAAA
binding completely lacked the characteristic BR1 interac-
tions seen in substrate ssDNAs, suggesting that the pres-
ence of the ribose sugar prevented both the ribocytidine
and the middle deoxycytidine from catalytically produc-
tive binding. Consistently, the real-time NMR deamina-
tion assay did not detect any deamination product from
5′-AATCCriboseCAAA (Figure 5B). To determine struc-
tural factors involved in DNA versus RNA differentiation,
we mixed A3Gctd-2K3A-E259A with ssDNAs containing
2′-F-ANA cytidine or 2′-F-RNA cytidine at the target po-
sition. Here, fluorine serves as an isopolar and isosteric
mimic of the native hydroxyl moiety in ribonucleotides,
retaining similar interbond distances and similar electro-
static properties, as Pauling electronegativities are 3.44 and
3.98 for O and F, respectively (60). Based on their chemi-
cal structures, 2′-F-ANA cytidine and 2′-F-RNA cytidine
are assumed to have the C2′-endo conformation and the
C3′-endo conformation, respectively (61) (Figure 4). Addi-
tion of 5′-ATTCC(2′-F-RNA)CAATT resulted in moder-
ate reduction of NMR signal intensities of A3Gctd-2K3A-
E259A for BR2 and BR3 (Supplementary Figure S2E),
yet lacked significant CSP and intensity change in BR1.
Since 5′-ATTCC(2′-F-RNA)CAATT was not deaminated
by A3Gctd-2K3A (Figure 5D), these results are consis-
tent with 5′-AATCCriboseCAAA, suggesting the C3′-endo
sugar conformation of the ribocytidine was disfavored for
the catalytically productive binding. In contrast, the ssDNA
containing a 2′-F-ANA cytidine exhibited interactions with
BR1 (Figure 3D, Supplementary Figure S2D), and the 2′-F-
ANA-cytidine was deaminated (Figure 5C), suggesting that
the propensity for 2′-F-ANA to retain the C2′-endo sugar
conformation of the native DNA allowed the catalytically
productive binding. Furthermore, the subsequent deamina-
tion of the middle deoxycytidine in the 5′-CC(2′-F-ANA)C
sequence (Figure 5C) suggested that the 2′-endo sugar con-
formation was also preferred for the nucleotide flanking
the 3′ side of the target deoxycytidine because A3Gctd-
2K3A did not deaminate the middle deoxycytidine of 5′-
ATTCCriboseCAATT nor 5′-ATTCC(2′-F-RNA)CAATT
(Figure 5B and D). The deamination rate for the 2′-F-ANA
cytidine was 0.06 ± 0.01 reactions/minute (Supplementary
Figure S4), which was over five times slower than that for
deoxycytidine, suggesting that fluorine at the 2′ position
negatively affected the catalytic interaction with A3Gctd.
Our results extended the finding of Nabel et al. (33) to
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A3Gctd, and provided experimental evidence as we showed
that the 2′-F-ANA (presumably 2′-endo conformation) al-
lowed the catalytically productive binding, but 2′-F-RNA
(presumably 3′-endo conformation) did not.
Since RNA is capable of adopting the 2′-endo sugar con-
formation, the remaining question is why the ribocytidine
assuming the 2′-endo sugar conformation is not efficiently
deaminated by A3Gctd. To answer this question, we inves-
tigated whether 2′-OH destabilizes the ribocytidine in the
2′-endo sugar conformation at the catalytic site of A3Gctd.
MD simulations showed that 2′-OH triggered structural
changes causing dislocation of the target base from the cat-
alytic position. Therefore, 2′-OHmay be another structural
feature that negatively affects the deamination of ribocyti-
dine by A3Gctd. On the other hand, A3A held ribocytidine
at the catalytic position in the MD simulation, consistent
with A3A’s ability to deaminate ribocytidines albeit less ef-
ficiently compared with deoxycytidine (NMR deamination
assay is provided as Supplementary Figure S5). For A3A,
the MD simulation showed that 2′-OH neither forms a hy-
drogen bond with the Zn2+-binding histidine (H70 in A3A),
nor triggered subsequent structural changes of residues in-
teracting with the target ribocytidine. The RMSD data in-
dicated that movements of residues interacting with the ri-
bocytidine were more restricted in A3A than A3Gctd (Sup-
plementary Table S1); therefore, the target ribocytidine was
stable at the catalytic position in A3A. Since A3A also
deaminates 5-methyl-cytidine as a substrate (62–64), study-
ing A3A further by using NMR andMD simulations to un-
derstand binding modes for DNA and RNA substrates will
be enlightening.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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